Bavunalimab

Tax included
Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer.
MedChemExpress 
HY-P99354

Data sheet

Size
Multiple sizes
Reactivity
CTLA-4
Application
COVID-19-immunoregulation
CAS
2329669-78-3